Isracann Biosciences Stock Probability of Future Pink Sheet Price Finishing Over 0.0
Isracann Biosciences' future price is the expected price of Isracann Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Isracann Biosciences performance during a given time horizon utilizing its historical volatility. Check out Isracann Biosciences Backtesting, Isracann Biosciences Valuation, Isracann Biosciences Correlation, Isracann Biosciences Hype Analysis, Isracann Biosciences Volatility, Isracann Biosciences History as well as Isracann Biosciences Performance.
Please specify Isracann Biosciences' target price for which you would like Isracann Biosciences odds to be computed.
Isracann |
Isracann Biosciences Target Price Odds to finish over 0.0
The tendency of Isracann Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.00 | 90 days | 0.00 | close to 99 |
Based on a normal probability distribution, the odds of Isracann Biosciences to move above the current price in 90 days from now is close to 99 (This Isracann Biosciences probability density function shows the probability of Isracann Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Isracann Biosciences has the beta coefficient that is very close to zero. This usually indicates the returns on DOW JONES INDUSTRIAL and Isracann Biosciences do not appear to be reactive. Additionally It does not look like Isracann Biosciences' alpha can have any bearing on the current valuation. Isracann Biosciences Price Density |
| Price |
Predictive Modules for Isracann Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Isracann Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Isracann Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Isracann Biosciences is not an exception. The market had few large corrections towards the Isracann Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Isracann Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Isracann Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.000027 | |
Ir | Information ratio | 0.00 |
Isracann Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Isracann Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Isracann Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Isracann Biosciences generated a negative expected return over the last 90 days | |
| Isracann Biosciences has high historical volatility and very poor performance | |
| Isracann Biosciences has some characteristics of a very speculative penny stock | |
| Isracann Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Isracann Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Isracann Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Isracann Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Isracann to invest in growth at high rates of return. When we think about Isracann Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Isracann Biosciences has accumulated about 310.61 K in cash with (1.75 M) of positive cash flow from operations. |
Isracann Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Isracann Pink Sheet often depends not only on the future outlook of the current and potential Isracann Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Isracann Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 158.3 M |
Isracann Biosciences Technical Analysis
Isracann Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Isracann Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Isracann Biosciences. In general, you should focus on analyzing Isracann Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Isracann Biosciences Predictive Forecast Models
Isracann Biosciences' time-series forecasting models is one of many Isracann Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Isracann Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Isracann Biosciences
Checking the ongoing alerts about Isracann Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Isracann Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Isracann Biosciences generated a negative expected return over the last 90 days | |
| Isracann Biosciences has high historical volatility and very poor performance | |
| Isracann Biosciences has some characteristics of a very speculative penny stock | |
| Isracann Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Isracann Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Isracann Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Isracann Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Isracann to invest in growth at high rates of return. When we think about Isracann Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Isracann Biosciences has accumulated about 310.61 K in cash with (1.75 M) of positive cash flow from operations. |
Other Information on Investing in Isracann Pink Sheet
Isracann Biosciences financial ratios help investors to determine whether Isracann Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isracann with respect to the benefits of owning Isracann Biosciences security.